Cohn & Wolfe
Tel: +34 91 531 50 97
Contact: Adriana Ibargüen
Almirall Media Relations
Tel: +34 93 291 30 00
Contact: Corporate Communications
Request further information about Almirall
You can request further information about Almirall by completing the form. All fields are compulsory, except those marked optional.
Almirall S.A. and Mercachem announced today that they have entered into an exclusive discovery collaboration focusing ...
Almirall and Nuevolution enter into a Strategic Collaboration to Develop RORγt inhibitors for treatment of Dermatology diseases and Psoriatic Arthritis
Almirall S.A. and Nuevolution A/S (a wholly owned subsidiary of Nuevolution AB (publ)) announced today that they have ...
Barcelona, 7 th November, 2016 .- Almirall, the global pharmaceutical company based in Barcelona, has announced its 9M ...
Almirall presents the derma story ‘Not Today' to raise awareness about the social impact of psoriasis
World Psoriasis Day (29 th October) Psoriasis affects more than 125M worldwide 1 . It can interfere with dail ...